Vascular Regulation by Super Enhancer-Derived LINC00607

Area of Science:

• Vascular Biology
• Epigenetics
• Molecular Medicine

Background:

• Endothelial cells (ECs) are crucial for vascular homeostasis.
• Long non-coding RNAs (lncRNAs) are emerging regulators of EC function.
• Super enhancer-derived lncRNAs (SE-lncRNAs) represent a key regulatory class.

Purpose of the Study:

• To investigate the role of LINC00607, a SE-lncRNA, in human arteries, focusing on ECs and vascular smooth muscle cells (VSMCs).
• To characterize LINC00607's expression and regulatory network in both healthy and diabetic vascular conditions.
• To explore LINC00607 as a potential therapeutic target for vascular dysfunction.

Main Methods:

• Analysis of public databases and single-cell RNA-sequencing (scRNA-seq) data from human arteries.
• RNA-sequencing to characterize transcriptomes regulated by LINC00607 in ECs and VSMCs.
• Transcriptomic and promoter analysis to identify upstream regulators (e.g., c-Myc).
• scRNA-seq to assess the efficacy of LINC00607 inhibition using antisense oligonucleotides.

Main Results:

• LINC00607 is highly expressed in human arteries and significantly increased in diabetic individuals.
• LINC00607 regulates distinct transcriptomes in ECs and VSMCs under basal and diabetic conditions.
• c-Myc was identified as an upstream transcription factor regulating LINC00607.
• Inhibition of LINC00607 reversed high glucose- and TNFα-induced EC dysfunction.

Conclusions:

• LINC00607 is a critical SE-lncRNA involved in vascular cell function and regulation.
• LINC00607 plays a significant role in vascular dysfunction associated with diabetes.
• Targeting LINC00607 with antisense oligonucleotides shows therapeutic potential for cardiovascular diseases.